History Is Showing Us How to Profit From the New Batch of “Miracle Drugs”

“Miracle drugs” can not only transform a user’s life… they can transform entire layers of our social fabric.

But it never comes easy. Mostly because cutting-edge medicine costs a lot of money.

A vial of insulin – which can last up to a month or two maximum – can cost up to $400 without insurance. The polio vaccine can cost up to $200 without insurance. And Chemotherapy can cost up to $200,000 without insurance.

The list goes on, and remember: these are today’s prices. Back when these treatments and medicines were developed, there was a scarcity problem and they cost a lot more.

It’s the same debate today with Ozempic, Wegovy, and the like. Novo Nordisk’s miracle weight-loss drug, semaglutide, in a five-year clinical trial published last year, showed that the drug cut the risk of cardiovascular disease among patients with obesity and heart disease by 20%.

And even though the study wasn’t intended to measure weight loss, participants who took the drug lost an average of 9.4% of total body weight.

So, it’s no wonder that prescriptions shot up five-fold within the past year, and by the end of last year, prescribers had nine million prescriptions on the books in the U.S. alone.

And it's also why Novo stock is up 52% and Eli Lilly, a competitor with a rival drug, Mounjaro, is up 62% this year.

Yet, the debate rages on whether insurance will cover this. A one-month dose of Ozempic costs $900 to manufacture. So, will the costs be worth it for insurance companies?

My Take: Yes, yes they will.

But it’s not necessarily about weight loss – exactly like Novo’s trial says.

Heart disease, as we all know by now, is America’s number one killer. Last year, deaths related to heart disease amounted to about 880,000 (one-third of all deaths in the U.S.).

What’s more are the costs associated with this. Heart disease costs the already broken American health care system $216 billion each year.

Just like with other miracle drugs in the past, manufacturing will soon become cheaper, and insurance companies are going to cover this because it’ll cost more not to.

This creates a massive profit opportunity web. And not necessarily with the drug makers.

You can see those right here.

Think about it – if over nine million people are prescribed a drug that’s proven wholly successful in taming weight, the implications in many sectors are going to be huge.

They’ll have to buy new clothes… Airline tickets may get cheaper… Insurance companies could take off… junk-food brands or less-healthy food options like Pepsi, Coke, or Yum! Brands may need to increase healthier options that cut at their margins.

Those opportunities are what you can find at Banyan Hill Publishing right here.